LGALS9 and neoplasm: The Chi-square test revealed that TIM-3 and Gal-9 were significantly correlated with NIH risk (P < 0.001 and P < 0.001), tumor size (P < 0.001 and P = 0.009), mitotic count (P < 0.001 and P = 0.035), and recurrence (P = 0.038 and P < 0.001).